Caris Life Sciences President David Baxley Spetzler disposes of USD 14.75 million in common shares - CAI News | RalliesCaris Life Sciences President David Baxley Spetzler disposes of USD 14.75 million in common shares
C
CAI• Insider share sales and option exercises
- Caris Life Sciences President David Baxley Spetzler sold 597,212 shares on Sept. 3–4 at about $24.76–$25.32.
- The transactions followed stock option exercises of 1,250,000 shares at $2.44.
- Beneficial ownership ended at 1,182,871 shares of common stock.
